Week in Review: April 14–18

Genome-wide effects of trisomy 21; RNA-based signs of transgenerational stress; depression and resilience; a call to overhaul US biomedical research system

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

U.S. DOE, HUMAN GENOME PROJECTThe third copy of chromosome 21—the hallmark of Down’s syndrome—can affect transcriptional regulation throughout the genome, a team led by investigators at the University of Geneva Medical School in Switzerland has found. Their work was published in Nature this week (April 16).

Studying a rare monozygotic twin pair in which only one sibling has the disorder, the Swiss team found striking differences in genome-wide gene expression between them. “The fact that they’ve got these really nice domain structures genome-wide further implicates the rising perception of the Down’s syndrome response as being more of a systems-level response,” Robin Dowell of the University of Colorado at Boulder, who was not involved in the work, told The Scientist.

WIKIMEDIA, RAMAMolecular remnants of early-life stress in mice can be passed down across generations, scientists from the University of Zurich in Switzerland and their colleagues showed in Nature Neuroscience this week (April 13). The team found that RNA-based markers in the sperm of rodents that were stressed early on in their lives correlated with certain aversive behaviors, and that these same marks could be found in their offspring, and in some cases, in their offspring’s offspring.

This study “really adds a new dimension in terms of what impact dad can have,” said Stephen Krawetz, the associate director of the C.S. Mott Center for Human Growth and Development at Wayne State University School of Medicine in Detroit, Michigan, who was not involved in the work.

FLICKR, LIFE MENTAL HEALTHIncreasing depression-causing neuronal activity in mice can reverse behaviors associated with the disorder, investigators at the Mount Sinai School of Medicine in New York have found. Their results were published in Science this week (April 17).

This work ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies